Cigna Corporation Profile Avatar - Palmy Investing

Cigna Corporation

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, …
Medical - Healthcare Plans
US, Bloomfield [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 43.32 79.95 79.63 80.74 82.17 81.41
Profit Margin
7.07 6.33 6.03 5.57 4.56 6.02 5.53 4.71 5.32 5.43 3.32 5.27 3.08 3.71 2.65
Operating Margin
10.30 9.64 9.86 8.50 6.72 9.49 8.83 7.57 10.26 8.38 -62.80 5.43 4.79 5.26 2.65
EPS Growth
352.38 -1.26 -0.85 22.58 -7.37 50.95 2.51 -10.53 25.45 16.58 27.04 70.62 -31.51 36.48 -18.88
Return on Assets (ROA)
3.03 2.94 2.60 3.02 2.72 3.76 3.67 3.15 3.62 1.72 3.28 5.44 3.47 4.66 3.49
Return on Equity (ROE)
24.04 20.24 15.90 16.61 13.97 19.51 17.40 13.60 16.29 6.43 11.26 16.81 11.40 14.94 11.17
Return on Invested Capital (ROIC)
16.37 15.58 10.89 10.85 9.35 13.18 12.13 9.91 13.93 3.60 -90.93 8.18 8.25 10.10 6.52
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
5.91 6.22 9.98 9.65 9.66 9.22 9.05 8.48 8.81 27.72 24.01 21.18 21.74 21.60 20.94
Debt/Equity
46.89 42.74 61.05 53.10 49.66 47.82 42.95 36.67 39.60 103.53 82.51 65.42 71.47 69.29 67.00
Debt/EBITDA
74.68 52.78 16.07 72.76 80.79 95.69 81.47 51.12 55.70 810.56 -35.30 197.44 253.56 202.32 458.13
Debt/Capitalization
31.92 29.94 37.91 34.68 33.18 32.35 30.05 26.83 28.37 50.87 45.21 39.55 41.68 40.93 40.12
Interest Debt per Share USD
9.27 11.08 19.56 18.21 19.73 19.52 20.18 19.71 23.33 174.24 103.98 94.13 103.20 104.41 110.30
Debt Growth
6.23 11.81 79.37 1.83 1.16 -1.81 0.33 -2.65 8.09 680.99 -11.94 -12.00 2.28 -7.65 1.25
Liquidity
Current Ratio
37,764.42 7,321.20 43,349.04 522.16 593.63 555.19 544.26 557.58 525.31 361.52 101.49 130.20 283.65 267.37 76.67
Quick Ratio
2,671.15 561.05 6,031.73 127.98 164.31 132.93 142.89 145.64 123.27 121.40 101.49 130.20 283.65 267.37 66.56
Cash Ratio
888.46 290.76 4,509.62 34.14 36.12 16.53 21.87 34.54 29.08 21.39 21.93 45.87 55.23 55.01 16.06
Operating Cash Flow Ratio
700 300 1,400 - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
- - - - - - - - - - - - - - - - - - 975.82 1,158.17 1,033.49 901.72 674.19 642.82
Receivables Turnover
1,352.98 1,612.52 1,619.88 362.49 348.55 354.93 360.48 415.15 446.03 303.94 972.07 923.33 867.24 822.56 824.30
Payables Turnover
- - - - - - - - - - - - - - - - - - 182.69 198.27 173.76 504.31 414.23 424.26
Asset Turnover
42.81 46.52 43.09 54.19 59.59 62.46 66.35 66.83 68.08 31.70 98.70 103.30 112.51 125.51 131.95
Coverage
Interest Coverage
- - 1,125.27 1,073.76 - - 824.24 - - - - - - 1,711.90 817.27 -5,739.89 605.98 691.39 773.86 357.12
Asset Coverage
1,600 1,500 900 800 800 900 900 900 900 200 200 300 300 300 200
Cash Flow Coverage (CFGR)
29.33 61.37 29.27 45.31 13.70 38.70 52.56 80.01 75.12 8.88 25.36 31.44 21.36 27.84 38.14
EBITDA Coverage
- - 1,200 1,200 - - 1,100 - - - - - - 1,700 900 -5,500 800 900 1,000 300
Dividend Coverage
-11,800 -12,200 -12,000 -14,700 -13,400 -19,100 - - - - - - - - - - -56,300 -400 -400 -300
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 - - - - - - - - 1,100 100
Market Prospects
Dividend Yield
0.11 0.11 0.10 0.07 0.05 0.04 - - - - - - - - - - 0.02 1.73 1.35 1.65
Earnings Yield
13.47 13.45 11.67 10.66 6.04 7.74 5.59 5.48 4.52 5.63 6.64 11.13 6.92 6.54 5.87
Price/Earnings (P/E)
742.40 743.74 856.75 938.17 1,655.34 1,291.95 1,789.98 1,824.45 2,214.90 1,776.42 1,506.11 898.34 1,445.18 1,529.91 1,704.22
Price/Book (P/B)
178.44 150.54 136.25 155.86 231.22 252.06 311.44 248.21 360.74 114.18 169.55 150.99 164.73 228.57 190.39
Price/Sales (P/S)
52.49 47.07 51.68 52.29 75.46 77.78 98.96 85.87 117.85 96.45 50.00 47.32 44.53 56.78 45.09
Price/Cash Flow (P/CF)
1,297.45 573.91 762.51 647.93 3,398.17 1,361.93 1,379.55 846.06 1,212.61 1,242.55 810.46 734.12 1,079.21 1,184.90 744.99
End of CI's Analysis
CIK: 1739940 CUSIP: 125523100 ISIN: US1255231003 LEI: - UEI: -
Secondary Listings